Imino acids are organic compounds containing a nitrogen atom in their structure, classified as derivatives of amino acids, where the carbon atom adjacent to the carboxyl group is bonded to a nitrogen atom instead of a hydrogen atom, forming a characteristic imino functional group.
A nontoxic radiopharmaceutical that is used in RADIONUCLIDE IMAGING for the clinical evaluation of hepatobiliary disorders in humans.
A radiopharmaceutical used extensively in cholescintigraphy for the evaluation of hepatobiliary diseases. (From Int Jrnl Rad Appl Inst 1992;43(9):1061-4)
The first artificially produced element and a radioactive fission product of URANIUM. Technetium has the atomic symbol Tc, atomic number 43, and atomic weight 98.91. All technetium isotopes are radioactive. Technetium 99m (m=metastable) which is the decay product of Molybdenum 99, has a half-life of about 6 hours and is used diagnostically as a radioactive imaging agent. Technetium 99 which is a decay product of technetium 99m, has a half-life of 210,000 years.
Preservative for wines, soft drinks, and fruit juices and a gentle esterifying agent.
A nontoxic radiopharmaceutical that is used in the clinical evaluation of hepatobiliary disorders in humans.
A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, liver, and spleen.
A gamma-emitting radionuclide imaging agent used primarily in skeletal scintigraphy. Because of its absorption by a variety of tumors, it is useful for the detection of neoplasms.
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS.
A radionuclide imaging agent used primarily in scintigraphy or tomography of the heart to evaluate the extent of the necrotic myocardial process. It has also been used in noninvasive tests for the distribution of organ involvement in different types of amyloidosis and for the evaluation of muscle necrosis in the extremities.
A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in cardiovascular and cerebral circulation.
A technetium imaging agent used in renal scintigraphy, computed tomography, lung ventilation imaging, gastrointestinal scintigraphy, and many other procedures which employ radionuclide imaging agents.
Inorganic compounds that contain TECHNETIUM as an integral part of the molecule. Technetium 99m (m=metastable) is an isotope of technetium that has a half-life of about 6 hours. Technetium 99, which has a half-life of 210,000 years, is a decay product of technetium 99m.
Organic compounds that contain technetium as an integral part of the molecule. These compounds are often used as radionuclide imaging agents.
A trace element that is required in bone formation. It has the atomic symbol Sn, atomic number 50, and atomic weight 118.71.
A gamma-emitting RADIONUCLIDE IMAGING agent used in the evaluation of regional cerebral blood flow and in non-invasive dynamic biodistribution studies and MYOCARDIAL PERFUSION IMAGING. It has also been used to label leukocytes in the investigation of INFLAMMATORY BOWEL DISEASES.
A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack.
A mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes.
A nontoxic radiopharmaceutical that is used in the diagnostic imaging of the renal cortex.
A technetium diagnostic aid used in renal function determination.
The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph.
"Ethyl ethers, also known as diethyl ether, is a colorless, highly volatile, and flammable liquid that belongs to the class of organic compounds called ethers, used as an anesthetic in medicine."
A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints.
**Maleates** are organic compounds that contain a carboxylic acid group and a hydroxyl group attached to adjacent carbon atoms, often used as intermediates in the synthesis of pharmaceuticals and other chemicals, or as drugs themselves, such as maleic acid or its salts.

Relationship of hepatic functional imaging to irinotecan pharmacokinetics and genetic parameters of drug elimination. (1/13)

PURPOSE: The marked variability of irinotecan (Ir) clearance warrants individualized dosing based on hepatic drug handling. The aims of this trial were to identify parameters from functional hepatic nuclear imaging (HNI) that correlate with (1) Ir pharmacology, and (2) single-nucleotide polymorphisms (SNPs) for the ABCB1 (P-glycoprotein) and UGT-1A1 genes, known to influence Ir handling. METHODS: Patients underwent genotyping for ABCB1 SNPs and UTUGT-1A1*28 carriage and HNI with 99mTc-DIDA (acetanilidoiminodiacetic acid)/99mTc-DISIDA (disofenin) and MIBI (99mTc-sestamibi) scans, probes for biliary transport proteins ABCC1 and -2, and ABCB1 function. HNI data were analyzed by noncompartmental and deconvolutional analysis to provide hepatic extraction and biliary excretion parameters. Patients received Ir, fluorouracil, and folinic acid using a weekly x2, every-3-weeks schedule. Plasma was taken for Ir and SN-38 analysis on day 1, cycle 1. RESULTS: Of the 21 patients accrued, Ir pharmacokinetics data were obtained from 16 patients. 99mTc-DIDA/DISIDA percent retention at 1 hour (1-hour RET) correlated to baseline serum bilirubin (P = .008). Both 99mTc-DIDA/DISIDA and MIBI 1-hour RET correlated with SN-38 area under the curve (AUC; P < .01). On multiple regression analysis, SN-38 AUC = -215 + 18.68 x bilirubin + 4.27 x MIBI 1-hour RET (P = .009, R2 = 44.2%). HNI parameters did not correlate with Ir toxicity or UGT1A1*28 carriage. MIBI excretion was prolonged in patients with the ABCB1 exon 26 TT variant allele relative to wild-type (P = .015). CONCLUSION: Functional imaging of hepatic uptake and excretory pathways may have potential to predict Ir pharmacokinetics. Evaluation of a larger cohort as well as polymorphisms in other biliary transporters and UGT1A1 alleles is warranted.  (+info)

Comparative evaluation of intragastric bile acids and hepatobiliary scintigraphy in the diagnosis of duodenogastric reflux. (2/13)

 (+info)

Predictive models for regional hepatic function based on 99mTc-IDA SPECT and local radiation dose for physiologic adaptive radiation therapy. (3/13)

 (+info)

75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. (4/13)

The purpose of this study was to evaluate whether bile acid malabsorption assessed by the 75SeHCAT test, had a pathogenetic role in functional chronic diarrhoea and to ascertain whether the small bowel transit time (SBTT) could be correlated with the 75SeHCAT test results. The test was based on the counting of the abdominal retention of a 75-selenium labelled homotaurocholic acid. The 75SeHCAT test was carried out in a control group of 23 healthy adults and in 46 patients, 38 of whom were suffering from irritable bowel syndrome (IBS) of diarrhoeic form and eight patients who had undergone cholecystectomy and were suffering from chronic diarrhoea. Faecal bile acid loss was determined in nine patients, and in 14, serum bile acid increase after a standard meal was measured. In 17, SBTT was studied by hydrogen breath test after lactulose administration (21 g in 300 ml water). In 15 patients, choledochocaecal transit time was estimated by Tc99m-HIDA (111 MBq) cholescintigraphy. In 20 of 46 subjects, 75SeHCAT retention was below normal level, and in 19 cholestyramine administration relieved diarrhoea. 75SeHCAT results were related to faecal bile acid loss, while no correlation was found with serum bile acids and SBTT. The data suggest a possible wider use of the 75SeHCAT test in chronic diarrhoea to estimate bile acid malabsorption in irritable bowel syndrome, diarrhoeic form, and provide an effective treatment. In our patients small bowel transit velocity does not seem to be a pathogenetic factor of bile acid malabsorption.  (+info)

Enterogastric reflux and gastric clearance of refluxate in normal subjects and in patients with and without bile vomiting following peptic ulcer surgery. (5/13)

A noninvasive scintigraphic technique was used to estimate enterogastric reflux and subsequent gastric evacuation of refluxate in 35 normal, healthy subjects and 55 patients previously treated by vagotomy or partial gastrectomy. Reflux was provoked by a milk drink and quantitated by counting 99Tcm-EHIDA activity within the gastric area during gamma camera imaging. Seven normal subjects (20%) showed reflux of 5-18% of initial activity (mean: 10%), with peak values occurring at 5-30 minutes (mean: 14 minutes) following the milk. Gastric evacuation of activity in these subjects was monoexponential (r = 0.993, T1/2 = 24.1 minutes). Reflux occurred more frequently than normal in patients with truncal vagotomy and drainage (22/28 patients) and partial gastrectomy (20/21 patients). All of 16 patients with Billroth II anastomoses exhibited reflux, which was excessive compared with refluxing normal subjects (mean: 25%; p less than 0.01) and occurred later into the study (mean: 34 minutes; p less than 0.01). Ten of 11 asymptomatic patients showed reflux of similar amounts of activity (mean: 21%) compared with 16 patients who complained of bile vomiting (mean: 22%). However, asymptomatic patients exhibited gastric evacuation of refluxate at a rate similar to that of refluxing normal subjects, while bile vomiters showed significant gastric retention of refluxate at 25-30 minutes following peak gastric activity (p less than 0.05). This result confirms that post-operative bile vomiting is essentially a problem of gastric emptying.  (+info)

Relationship between gastric emptying of solids and gall bladder emptying in normal subjects. (6/13)

Very little is known about the normal temporal and quantitative relationships between gastric emptying and gall bladder emptying. Using a non-invasive double isotope technique these relationships were investigated in 22 normal healthy adults. 99Tcm EHIDA was used as the biliary tracer and 113Inm labelled bran as the gastric content tracer. Gastric emptying was monoexponential with a t1/2 of 45 +/- 3 minutes (mean +/- SEM). In 15 subjects the gall bladder emptied in relation to eating according to a double exponential function. In these subjects 15.0 +/- 1.6% of gall bladder contents emptied before gastric emptying began. They could be further divided into two clear cut types (p less than 0.001), according to the ejection fraction at 10 minutes and the t1/2 of the first exponential. Emptying of the gall bladder was faster and more of its contents were ejected in subjects with a type I response (n = 9) than in subjects with a type II response (n = 6). In the remaining seven subjects the gall bladder began to empty spontaneously, unrelated to eating. These observations suggest that gall bladder emptying: (a) may have a cephalic phase, (b) can be expressed as a double exponential function, (c) may occur unrelated to eating, (d) which occurs only in relation to eating would appear to be either fast (type I) or slow (type II).  (+info)

Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents. (7/13)

The radiation absorbed doses from five commercially available hepatobiliary agents--Tc-99m-tagged analogs of IDA (EIDA, PIPIDA, HIDA, PBIDA, DISIDA) have been calculated from biokinetic data in 41 normal subjects. Serial gamma images, with blood and urine samples, were obtained to calculate cumulated radioactivity in the source organs: blood, kidney, bladder, liver, gallbladder, and intestines. The critical organ was the gallbladder, with an absorbed-dose range of 690 to 780 mrad/mCl. Absorbed doses for other target organs were: upper large intestine 320 to 370 mrad/mCi, lower large intestine 210 to 240, small intestine 170 to 200, liver 65 (DISIDA) to 130 (PBIDA), ovaries 63 to 72, and urinary bladder wall 23 (PBIDA) to 36 (EIDA). The radiation absorbed dose was largely independent of changes in chemical structure except in (a) the liver, where absorbed dose varied by a factor of two in proportion to the rate of excretion of the IDA agent from the liver, and (b) the urinary bladder, where absorbed dose varied by a factor of 1.6 because of differences in rate of excretion. When the stimulus for gallbladder emptying is changed from whole-meal ingestion to cholecystokinin injection, the absorbed dose to the gallbladder increases to approximately 1 rad/mCi; if no gallbladder emptying is assumed, its absorbed dose increases to approximately 1.9 rad/mCi. In the absence of contraindication, the gallbladder absorbed dose may thus be decreased by inducing gallbladder emptying at the end of the imaging study.  (+info)

Interdigestive biliary output in man: relationship to fluctuations in plasma motilin and effect of atropine. (8/13)

The fasting output of bile into the bowel was investigated in nine healthy volunteers by hepatobiliary scanning. Subjects were studied twice, on each occasion for 2.5 hours. A significant flow of radioactivity from the gall bladder to the duodenum was observed on one or two occasions during each experiment. A 32 +/- 4% mean decrease in counts over the gall bladder was recorded, indicating partial emptying of this organ in the interdigestive state. The output of bile into the bowel was found to be related to fluctuations in fasting plasma motilin levels in that a significant motilin increment (18 +/- 4 pmol/l, p less than 0.005) paralleled the appearance of radioactivity in the duodenum. The onset of gall-bladder emptying regularly preceded the peak in plasma motilin (mean: 25 +/- 2 minutes). Atropine, intravenously, 0.6 mg followed by 0.3 mg, nearly abolished both fasting biliary output and plasma motilin fluctuations. Thus, bile output appears to occur frequently in fasting humans, but our data do not allow any conclusions as to the possible causal relationship between fasting gall-bladder emptying and release of motilin. Cholinergic influences appear to be of importance in the regulation of interdigestive biliary output in man.  (+info)

Imino acids are organic compounds that contain a nitrogen atom as part of an amide-like structure. They are structurally similar to amino acids, which contain a carboxyl group and an amino group, but instead of the amino group, imino acids have a structural unit known as an imine or Schiff base, which is a carbon-nitrogen double bond with a hydrogen atom attached to the nitrogen atom.

One example of an imino acid is proline, which is a cyclic imino acid that plays important roles in protein structure and function. Proline is unique among the 20 standard amino acids because its side chain is linked to the nitrogen atom of the backbone, forming a ring-like structure. This structural feature gives proline unique properties, such as restricted rotation around the bond between the nitrogen and alpha carbon atoms, which can affect protein folding and stability.

Other imino acids may be formed through chemical reactions or enzymatic processes, and they can play important roles in various biological pathways, including the biosynthesis of amino acids, nucleotides, and other biomolecules. However, imino acids are not typically considered to be part of the standard set of 20 amino acids that make up proteins.

Technetium Tc 99m Lidofenin is a radiopharmaceutical used in nuclear medicine imaging procedures, specifically for hepatobiliary scintigraphy. It is a technetium-labeled compound, where the radioisotope technetium-99m (^99m^Tc) is bound to lidofenin, a liver-imaging agent.

The compound is used to assess the function and anatomy of the liver, gallbladder, and biliary system. After intravenous administration, Technetium Tc 99m Lidofenin is taken up by hepatocytes (liver cells) and excreted into the bile ducts and ultimately into the small intestine. The distribution and excretion of this radiopharmaceutical can be monitored using a gamma camera, providing functional information about the liver and biliary system.

It is essential to note that the use of Technetium Tc 99m Lidofenin should be under the guidance and supervision of healthcare professionals trained in nuclear medicine, as its administration and handling require specific expertise and safety measures due to the radioactive nature of the compound.

Technetium Tc 99m Disofenin is not a medical condition, but rather a radiopharmaceutical used in diagnostic imaging. It is a radioactive tracer used in nuclear medicine scans, specifically for liver and biliary system imaging. The compound consists of the radioisotope Technetium-99m (Tc-99m) bonded to the pharmaceutical Disofenin.

The Tc-99m is a gamma emitter with a half-life of 6 hours, making it ideal for diagnostic imaging. When administered to the patient, the compound is taken up by the liver and excreted into the bile ducts and gallbladder, allowing medical professionals to visualize these structures using a gamma camera. This can help detect various conditions such as tumors, gallstones, or obstructions in the biliary system.

It's important to note that Technetium Tc 99m Disofenin is used diagnostically and not for therapeutic purposes. The radiation exposure from this compound is generally low and considered safe for diagnostic use. However, as with any medical procedure involving radiation, the benefits and risks should be carefully weighed and discussed with a healthcare professional.

Technetium is not a medical term itself, but it is a chemical element with the symbol Tc and atomic number 43. However, in the field of nuclear medicine, which is a branch of medicine that uses small amounts of radioactive material to diagnose or treat diseases, Technetium-99m (a radioisotope of technetium) is commonly used for various diagnostic procedures.

Technetium-99m is a metastable nuclear isomer of technetium-99, and it emits gamma rays that can be detected outside the body to create images of internal organs or tissues. It has a short half-life of about 6 hours, which makes it ideal for diagnostic imaging since it decays quickly and reduces the patient's exposure to radiation.

Technetium-99m is used in a variety of medical procedures, such as bone scans, lung scans, heart scans, liver-spleen scans, brain scans, and kidney scans, among others. It can be attached to different pharmaceuticals or molecules that target specific organs or tissues, allowing healthcare professionals to assess their function or identify any abnormalities.

Diethyl pyrocarbonate (DEPC) is a chemical compound with the formula (C2H5O)2CO. It is a colorless, volatile liquid that is used as a disinfectant and sterilizing agent, particularly for laboratory equipment and solutions. DEPC works by reacting with amino groups in proteins, forming covalent bonds that inactivate enzymes and other proteins. This makes it effective at destroying bacteria, viruses, and spores.

However, DEPC is also reactive with nucleic acids, including DNA and RNA, so it must be removed or deactivated before using solutions treated with DEPC for molecular biology experiments. DEPC can be deactivated by heating the solution to 60-70°C for 30 minutes to an hour, which causes it to hydrolyze into ethanol and carbon dioxide.

It is important to handle DEPC with care, as it can cause irritation to the skin, eyes, and respiratory tract. It should be used in a well-ventilated area or under a fume hood, and protective clothing, gloves, and eye/face protection should be worn when handling the chemical.

Technetium Tc 99m Diethyl-iminodiacetic Acid (Tc 99m DTPA) is a radiopharmaceutical agent used in medical imaging. It is a technetium-labeled compound, where the radioisotope technetium-99m is bound to diethyl-iminodiacetic acid (DTPA). This complex is used as a renal agent for performing nuclear medicine imaging studies to assess kidney function and structure.

Technetium-99m is a metastable isotope of technetium that emits gamma rays, making it suitable for medical imaging. When Tc 99m DTPA is injected into the patient's body, it is excreted primarily by the kidneys through glomerular filtration and tubular secretion. The gamma rays emitted by technetium-99m are detected by a gamma camera, which generates images of the distribution and excretion of the radiopharmaceutical within the kidneys. This information helps physicians evaluate kidney function, detect abnormalities such as obstructions or tumors, and monitor the effectiveness of treatments.

It is essential to handle and administer Tc 99m DTPA with care due to its radioactive nature, following proper safety guidelines and regulations to ensure patient and staff safety.

Technetium Tc 99m Sulfur Colloid is a radioactive tracer used in medical imaging procedures, specifically in nuclear medicine. It is composed of tiny particles of sulfur colloid that are labeled with the radioisotope Technetium-99m. This compound is typically injected into the patient's body, where it accumulates in certain organs or tissues, depending on the specific medical test being conducted.

The radioactive emissions from Technetium Tc 99m Sulfur Colloid are then detected by a gamma camera, which produces images that can help doctors diagnose various medical conditions, such as liver disease, inflammation, or tumors. The half-life of Technetium-99m is approximately six hours, which means that its radioactivity decreases rapidly and is eliminated from the body within a few days.

Technetium Tc 99m Medronate is a radiopharmaceutical agent used in nuclear medicine for bone scintigraphy. It is a technetium-labeled bisphosphonate compound, which accumulates in areas of increased bone turnover and metabolism. This makes it useful for detecting and evaluating various bone diseases and conditions, such as fractures, tumors, infections, and arthritis.

The "Tc 99m" refers to the radioisotope technetium-99m, which has a half-life of approximately 6 hours and emits gamma rays that can be detected by a gamma camera. The medronate component is a bisphosphonate molecule that binds to hydroxyapatite crystals in bone tissue, allowing the radiolabeled compound to accumulate in areas of active bone remodeling.

Overall, Technetium Tc 99m Medronate is an important tool in nuclear medicine for diagnosing and managing various musculoskeletal disorders.

Chelating agents are substances that can bind and form stable complexes with certain metal ions, preventing them from participating in chemical reactions. In medicine, chelating agents are used to remove toxic or excessive amounts of metal ions from the body. For example, ethylenediaminetetraacetic acid (EDTA) is a commonly used chelating agent that can bind with heavy metals such as lead and mercury, helping to eliminate them from the body and reduce their toxic effects. Other chelating agents include dimercaprol (BAL), penicillamine, and deferoxamine. These agents are used to treat metal poisoning, including lead poisoning, iron overload, and copper toxicity.

Technetium Tc 99m Pyrophosphate (Tc-99m PYP) is a radiopharmaceutical agent used in nuclear medicine imaging, specifically myocardial perfusion imaging. It is a complex of technetium-99m, a metastable isotope of technetium, with pyrophosphate, a molecule that accumulates in damaged heart muscle tissue.

When injected into the patient's bloodstream, Tc-99m PYP is taken up by the heart muscle in proportion to its blood flow and the degree of damage or scarring (fibrosis). This allows for the detection and evaluation of conditions such as myocardial infarction (heart attack), cardiomyopathy, and heart transplant rejection.

The imaging procedure involves the injection of Tc-99m PYP, followed by the acquisition of images using a gamma camera, which detects the gamma rays emitted by the technetium-99m isotope. The resulting images provide information about the distribution and extent of heart muscle damage, helping physicians to make informed decisions regarding diagnosis and treatment planning.

Technetium Tc 99m Aggregated Albumin is a radiopharmaceutical preparation used in diagnostic imaging. It consists of radioactive technetium-99m (^99m^Tc) chemically bonded to human serum albumin, which has been aggregated to increase its size and alter its clearance from the body.

The resulting compound is injected into the patient's bloodstream, where it accumulates in the reticuloendothelial system (RES), including the liver, spleen, and bone marrow. The radioactive emission of technetium-99m can then be detected by a gamma camera, producing images that reflect the distribution and function of the RES.

This imaging technique is used to diagnose and monitor various conditions, such as liver disease, inflammation, or tumors. It provides valuable information about the patient's health status and helps guide medical decision-making.

Technetium Tc 99m Pentetate is a radioactive pharmaceutical preparation used as a radiopharmaceutical agent in medical imaging. It is a salt of technetium-99m, a metastable nuclear isomer of technetium-99, which emits gamma rays and has a half-life of 6 hours.

Technetium Tc 99m Pentetate is used in various diagnostic procedures, including renal imaging, brain scans, lung perfusion studies, and bone scans. It is distributed throughout the body after intravenous injection and is excreted primarily by the kidneys, making it useful for evaluating renal function and detecting abnormalities in the urinary tract.

The compound itself is a colorless, sterile, pyrogen-free solution that is typically supplied in a lead shielded container to protect against radiation exposure. It should be used promptly after preparation and handled with care to minimize radiation exposure to healthcare workers and patients.

Technetium compounds refer to chemical substances that contain the radioactive technetium (Tc) element. Technetium is a naturally rare element and does not have any stable isotopes, making it only exist in trace amounts in the Earth's crust. However, it can be produced artificially in nuclear reactors.

Technetium compounds are widely used in medical imaging as radioactive tracers in diagnostic procedures. The most common technetium compound is Technetium-99m (Tc-99m), which has a half-life of 6 hours and emits gamma rays that can be detected by external cameras. Tc-99m is often bound to various pharmaceuticals, such as methylene diphosphonate (MDP) or human serum albumin (HSA), to target specific organs or tissues in the body.

Technetium compounds are used in a variety of diagnostic procedures, including bone scans, lung perfusion scans, myocardial perfusion imaging, and brain scans. They provide valuable information about organ function, blood flow, and tissue metabolism, helping doctors diagnose various medical conditions such as cancer, heart disease, and bone fractures.

It is important to note that technetium compounds should only be used under the supervision of trained medical professionals due to their radioactive nature. Proper handling, administration, and disposal procedures must be followed to ensure safety and minimize radiation exposure.

Organotechnetium compounds are chemical substances that contain carbon-technetium bonds, where technetium is an element with the symbol Tc and atomic number 43. These types of compounds are primarily used in medical imaging as radioactive tracers due to the ability of technetium-99m to emit gamma rays. The organotechnetium compounds help in localizing specific organs, tissues, or functions within the body, making them useful for diagnostic purposes in nuclear medicine.

It is important to note that most organotechnetium compounds are synthesized from technetium-99m, which is generated from the decay of molybdenum-99. The use of these compounds requires proper handling and administration by trained medical professionals due to their radioactive nature.

I'm sorry for any confusion, but "Tin" does not have a medical definition. Tin is a chemical element with the symbol Sn and atomic number 50. It is a malleable, ductile, silvery-white post-transition metal. It is found in nature mainly as tin oxides and is obtained from the mineral cassiterite through mining and processing.

Tin has no known biological role in humans, animals, or plants, and it is not considered an essential nutrient. Small amounts of tin can be found in some foods and drinking water, but these levels are generally low and not considered harmful. High levels of tin can be toxic to the human body, causing symptoms such as nausea, vomiting, and diarrhea.

If you have any questions about a medical condition or treatment, I would recommend consulting with a healthcare professional for accurate information and guidance.

Technetium Tc 99m Exametazime is a radiopharmaceutical agent used in nuclear medicine imaging procedures. The compound consists of the radioisotope Technetium-99m (^99m^Tc) bonded to Exametazime, also known as HMPAO (hexamethylpropyleneamine oxime).

Once injected into the patient's bloodstream, Technetium Tc 99m Exametazime distributes evenly throughout the brain, crossing the blood-brain barrier and entering cells. The radioactive decay of Technetium-99m emits gamma rays that can be detected by a gamma camera, creating images of the brain's blood flow and distribution of the tracer.

This imaging technique is often used in cerebral perfusion studies to assess conditions such as stroke, epilepsy, or dementia, providing valuable information about regional cerebral blood flow and potential areas of injury or abnormality.

Technetium Tc 99m Sestamibi is a radiopharmaceutical compound used in medical imaging, specifically in myocardial perfusion scintigraphy. It is a technetium-labeled isonitrile chelate that is taken up by mitochondria in cells with high metabolic activity, such as cardiomyocytes (heart muscle cells).

Once injected into the patient's body, Technetium Tc 99m Sestamibi emits gamma rays, which can be detected by a gamma camera. This allows for the creation of images that reflect the distribution and function of the radiopharmaceutical within the heart muscle. The images can help identify areas of reduced blood flow or ischemia, which may indicate coronary artery disease.

The uptake of Technetium Tc 99m Sestamibi in other organs, such as the breast and thyroid, can also be used for imaging purposes, although its primary use remains in cardiac imaging.

In medical terms, "ether" is an outdated term that was used to refer to a group of compounds known as diethyl ethers. The most common member of this group, and the one most frequently referred to as "ether," is diethyl ether, also known as sulfuric ether or simply ether.

Diethyl ether is a highly volatile, flammable liquid that was once widely used as an anesthetic agent in surgical procedures. It has a characteristic odor and produces a state of unconsciousness when inhaled, allowing patients to undergo surgery without experiencing pain. However, due to its numerous side effects, such as nausea, vomiting, and respiratory depression, as well as the risk of explosion or fire during use, it has largely been replaced by safer and more effective anesthetic agents.

It's worth noting that "ether" also has other meanings in different contexts, including a term used to describe a substance that produces a feeling of detachment from reality or a sense of unreality, as well as a class of organic compounds characterized by the presence of an ether group (-O-, a functional group consisting of an oxygen atom bonded to two alkyl or aryl groups).

Technetium Tc 99m Dimercaptosuccinic Acid (DMSA) is a radiopharmaceutical agent used in nuclear medicine imaging procedures. The compound is made up of the radioisotope Technetium-99m, which emits gamma rays that can be detected by a gamma camera, and dimercaptosuccinic acid, which binds to certain types of metal ions in the body.

In medical imaging, Technetium Tc 99m DMSA is typically used to visualize the kidneys and detect any abnormalities such as inflammation, infection, or tumors. The compound is taken up by the renal tubules in the kidneys, allowing for detailed images of the kidney structure and function to be obtained.

It's important to note that the use of Technetium Tc 99m DMSA should be under the supervision of a trained medical professional, as with any radiopharmaceutical agent, due to the radiation exposure involved in its use.

Technetium Tc 99m Mertiatide is a radiopharmaceutical used in nuclear medicine imaging procedures. It is a technetium-labeled compound, where the radioisotope technetium-99m (^99m^Tc) is bound to mercaptoacetyltriglycine (MAG3). The resulting complex is known as ^99m^Tc-MAG3 or Technetium Tc 99m Mertiatide.

This radiopharmaceutical is primarily used for renal function assessment, including evaluation of kidney blood flow, glomerular filtration rate (GFR), and detection of renal obstructions or other abnormalities. After intravenous administration, Technetium Tc 99m Mertiatide is rapidly excreted by the kidneys, allowing for visualization and quantification of renal function through gamma camera imaging.

It's important to note that the use of radiopharmaceuticals should be performed under the guidance of a qualified healthcare professional, as they involve the administration of radioactive materials for diagnostic purposes.

Radionuclide imaging, also known as nuclear medicine, is a medical imaging technique that uses small amounts of radioactive material, called radionuclides or radiopharmaceuticals, to diagnose and treat various diseases and conditions. The radionuclides are introduced into the body through injection, inhalation, or ingestion and accumulate in specific organs or tissues. A special camera then detects the gamma rays emitted by these radionuclides and converts them into images that provide information about the structure and function of the organ or tissue being studied.

Radionuclide imaging can be used to evaluate a wide range of medical conditions, including heart disease, cancer, neurological disorders, gastrointestinal disorders, and bone diseases. The technique is non-invasive and generally safe, with minimal exposure to radiation. However, it should only be performed by qualified healthcare professionals in accordance with established guidelines and regulations.

Ethyl ether, also known as diethyl ether or simply ether, is a type of organic compound that is classified as a simple ether. It is a colorless and highly volatile liquid with a characteristic odor that is often described as sweet or fruity. In medical contexts, ethyl ether has been historically used as an anesthetic agent due to its ability to produce unconsciousness and insensitivity to pain when inhaled. However, its use as an anesthetic has largely been replaced by safer and more effective alternatives due to its flammability, explosiveness, and potential for causing serious adverse effects such as heart problems and liver damage.

Ethyl ether is a simple ether consisting of two ethyl groups (-C2H5) linked to an oxygen atom (O), with the molecular formula C4H10O. It is produced by the reaction of ethanol with sulfuric acid, followed by distillation to separate the resulting ethyl ether from other products.

In addition to its historical use as an anesthetic, ethyl ether has been used in various industrial and laboratory applications, such as a solvent for fats, oils, resins, and waxes, and as a starting material for the synthesis of other chemicals. However, due to its flammability and potential for causing harm, it is important to handle ethyl ether with care and follow appropriate safety precautions when using it.

Sodium Pertechnetate Tc 99m is a radioactive pharmaceutical preparation used in medical diagnostic imaging. It is a technetium-99m radiopharmaceutical, where technetium-99m is a metastable nuclear isomer of technetium-99, which emits gamma rays and has a half-life of 6 hours. Sodium Pertechnetate Tc 99m is used as a contrast agent in various diagnostic procedures, such as imaging of the thyroid, salivary glands, or the brain, to evaluate conditions like inflammation, tumors, or abnormalities in blood flow. It is typically administered intravenously, and its short half-life ensures that the radiation exposure is limited.

"Maleate" is not a medical term in and of itself, but it is a chemical compound that can be found in some medications. Maleic acid or its salts (maleates) are used as a keratolytic agent in topical medications, which means they help to break down and remove dead skin cells. They can also be used as a preservative or a buffering agent in various pharmaceutical preparations.

Maleic acid is a type of organic compound known as a dicarboxylic acid, which contains two carboxyl groups. In the case of maleic acid, these carboxyl groups are located on a single carbon atom, which makes it a cis-conjugated diacid. This structural feature gives maleic acid unique chemical properties that can be useful in various pharmaceutical and industrial applications.

It's worth noting that maleic acid and its salts should not be confused with "maleate" as a gender-specific term, which refers to something related to or characteristic of males.

... technetium tc 99m diethyl-iminodiacetic acid MeSH D12.125.072.401.840 - technetium tc 99m disofenin MeSH D12.125.072.401.900 - ... technetium tc 99m lidofenin MeSH D12.125.072.415 - isodesmosine MeSH D12.125.095.104 - arginine MeSH D12.125.095.104.075 - ... 2-aminoadipic acid MeSH D12.125.119.170 - aspartic acid MeSH D12.125.119.170.150 - d-aspartic acid MeSH D12.125.119.170.275 - ... aspartic acid MeSH D12.125.067.500.150 - d-aspartic acid MeSH D12.125.067.500.275 - isoaspartic acid MeSH D12.125.067.500.400 ...
... technetium tc 99m diethyl-iminodiacetic acid MeSH D02.691.825.468 - technetium tc 99m dimercaptosuccinic acid MeSH D02.691. ... technetium tc 99m diethyl-iminodiacetic acid MeSH D02.241.081.583.450 - technetium tc 99m disofenin MeSH D02.241.081.583.900 - ... technetium tc 99m diethyl-iminodiacetic acid MeSH D02.491.485.450 - technetium tc 99m disofenin MeSH D02.491.485.900 - ... technetium tc 99m disofenin MeSH D02.691.825.562 - technetium tc 99m exametazime MeSH D02.691.825.710 - technetium tc 99m ...
... technetium tc 99m diethyl-iminodiacetic acid MeSH D12.125.072.401.840 - technetium tc 99m disofenin MeSH D12.125.072.401.900 - ... technetium tc 99m lidofenin MeSH D12.125.072.415 - isodesmosine MeSH D12.125.095.104 - arginine MeSH D12.125.095.104.075 - ... 2-aminoadipic acid MeSH D12.125.119.170 - aspartic acid MeSH D12.125.119.170.150 - d-aspartic acid MeSH D12.125.119.170.275 - ... aspartic acid MeSH D12.125.067.500.150 - d-aspartic acid MeSH D12.125.067.500.275 - isoaspartic acid MeSH D12.125.067.500.400 ...
Technetium Tc 99m Aggregated Albumin. *Technetium Tc 99m Diethyl-iminodiacetic Acid. *Technetium Tc 99m Dimercaptosuccinic Acid ... "Technetium Tc 99m Exametazime" by people in this website by year, and whether "Technetium Tc 99m Exametazime" was a major or ... "Technetium Tc 99m Exametazime" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH ( ... Below are the most recent publications written about "Technetium Tc 99m Exametazime" by people in Profiles. ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
IDA, Tc-99m-Diethyl use Technetium Tc 99m Diethyl-iminodiacetic Acid IDA, Technetium-99m-Diethyl use Technetium Tc 99m Diethyl- ... 99m-Tc-Diethyl use Technetium Tc 99m Diethyl-iminodiacetic Acid IDA, 99mTc-Diethyl use Technetium Tc 99m Diethyl-iminodiacetic ...
The role of 99mtechnetium (Tc) diethyl-iminodiacetic acid (EHIDA) hepatobiliary scintigraphy in the diagnosis of a rare cause ... Sivelli R, Farinon AM, Sianesi M, Percudani M, Ugolotti G, Calbiani B. Technetium-99m HIDA hepatobiliary scanning in evaluation ... 2] Bacteria deconjugate bile acids, which can lead to steatorrhea, malnutrition, and vitamin B-12 deficiency leading to ...
99mTc-Diethyl IDA use Technetium Tc 99m Diethyl-iminodiacetic Acid 99mTc-Dimercaptosuccinic Acid use Technetium Tc 99m ... 12-S-HETE use 12-Hydroxy-5.8,10,14-eicosatetraenoic Acid 12-S-Hydroxyeicosatetraenoic Acid use 12-Hydroxy-5.8,10,14- ... Dimercaptosuccinic Acid 99mTc-DMSA use Technetium Tc 99m Dimercaptosuccinic Acid 99mTc-Hexamibi use Technetium Tc 99m Sestamibi ... 99mTc-Sestamibi use Technetium Tc 99m Sestamibi 99Tc-Succimer use Technetium Tc 99m Dimercaptosuccinic Acid ...
99mTc-Diethyl IDA use Technetium Tc 99m Diethyl-iminodiacetic Acid 99mTc-Dimercaptosuccinic Acid use Technetium Tc 99m ... 12-S-HETE use 12-Hydroxy-5.8,10,14-eicosatetraenoic Acid 12-S-Hydroxyeicosatetraenoic Acid use 12-Hydroxy-5.8,10,14- ... Dimercaptosuccinic Acid 99mTc-DMSA use Technetium Tc 99m Dimercaptosuccinic Acid 99mTc-Hexamibi use Technetium Tc 99m Sestamibi ... 99mTc-Sestamibi use Technetium Tc 99m Sestamibi 99Tc-Succimer use Technetium Tc 99m Dimercaptosuccinic Acid ...
99mTc-Diethyl IDA use Technetium Tc 99m Diethyl-iminodiacetic Acid 99mTc-Dimercaptosuccinic Acid use Technetium Tc 99m ... 12-S-HETE use 12-Hydroxy-5.8,10,14-eicosatetraenoic Acid 12-S-Hydroxyeicosatetraenoic Acid use 12-Hydroxy-5.8,10,14- ... Dimercaptosuccinic Acid 99mTc-DMSA use Technetium Tc 99m Dimercaptosuccinic Acid 99mTc-Hexamibi use Technetium Tc 99m Sestamibi ... 99mTc-Sestamibi use Technetium Tc 99m Sestamibi 99Tc-Succimer use Technetium Tc 99m Dimercaptosuccinic Acid ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
98; TECHNETIUM TC 99M DIETHYL IDA (now TECHNETIUM TC 99M DIETHYL-IMINODIACETIC ACID) was indexed under IMINO ACIDS 1977-97, ... 99m-Tc-Diethyl IDA 99mTc-Diethyl IDA 99mTc-Diethyliminodiacetic Acid 99mTc-EHIDA Tc-99m-Diethyl IDA Technetium Tc 99m Diethyl ... Imino Acids [D02.241.081.583] * Azetidinecarboxylic Acid [D02.241.081.583.100] * Technetium Tc 99m Diethyl-iminodiacetic Acid [ ... Imino Acids [D02.491.485] * Azetidinecarboxylic Acid [D02.491.485.100] * Technetium Tc 99m Diethyl-iminodiacetic Acid [D02.491. ...
98; TECHNETIUM TC 99M DIETHYL IDA (now TECHNETIUM TC 99M DIETHYL-IMINODIACETIC ACID) was indexed under IMINO ACIDS 1977-97, ... 99m-Tc-Diethyl IDA 99mTc-Diethyl IDA 99mTc-Diethyliminodiacetic Acid 99mTc-EHIDA Tc-99m-Diethyl IDA Technetium Tc 99m Diethyl ... Imino Acids [D02.241.081.583] * Azetidinecarboxylic Acid [D02.241.081.583.100] * Technetium Tc 99m Diethyl-iminodiacetic Acid [ ... Imino Acids [D02.491.485] * Azetidinecarboxylic Acid [D02.491.485.100] * Technetium Tc 99m Diethyl-iminodiacetic Acid [D02.491. ...
Tc-99m-Diethyl IDA Technetium 99m Diethyl IDA Technetium Tc 99m Diethyl IDA Technetium Tc 99m Diethyl iminodiacetic Acid ... Tc 99m Diethyl IDA. Tc-99m-Diethyl IDA. Technetium 99m Diethyl IDA. Technetium Tc 99m Diethyl IDA. Technetium Tc 99m Diethyl ... Acid, 99mTc-Diethyliminodiacetic IDA, 99m-Tc-Diethyl IDA, 99mTc-Diethyl IDA, Tc-99m-Diethyl IDA, Technetium-99m-Diethyl Tc 99m ... Technetium Tc 99m Diethyl-iminodiacetic Acid Entry term(s). 99m Tc Diethyl IDA 99m-Tc-Diethyl IDA 99mTc Diethyl IDA 99mTc ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
D1.632.825.375 Technetium Tc 99m Diethyl-iminodiacetic Acid D1.632.825.445 Technetium Tc 99m Dimercaptosuccinic Acid D1.632. ... 825.468 Technetium Tc 99m Disofenin D1.632.825.475 Technetium Tc 99m Exametazime D1.632.825.562 Technetium Tc 99m Lidofenin ... D1.632.825.710 Technetium Tc 99m Medronate D1.632.825.750 Technetium Tc 99m Mertiatide D1.632.825.775 Technetium Tc 99m ... D1.632.825.875 Technetium Tc 99m Sestamibi D1.632.825.937 Technology, Medical H2.10.825 H2.10.450 J1.897.780 J1.897.480 ( ...
Imino Acids [D02.241.081.583] * Azetidinecarboxylic Acid [D02.241.081.583.100] * Technetium Tc 99m Diethyl-iminodiacetic Acid [ ... Imino Acids [D02.491.485] * Azetidinecarboxylic Acid [D02.491.485.100] * Technetium Tc 99m Diethyl-iminodiacetic Acid [D02.491. ... Amino Acids, Peptides, and Proteins [D12] * Amino Acids [D12.125] * Amino Acids, Cyclic [D12.125.072] * Amino Acids, Aromatic [ ... Technetium Tc 99m Diethyl-iminodiacetic Acid [D12.125.072.401.830] * Technetium Tc 99m Disofenin [D12.125.072.401.840] ...
Technetium Tc 99m Aggregated Albumin N0000170258 Technetium Tc 99m Diethyl-iminodiacetic Acid N0000166770 Technetium Tc 99m ... Tc 99m Lidofenin N0000166767 Technetium Tc 99m Medronate N0000170314 Technetium Tc 99m Mertiatide N0000166768 Technetium Tc 99m ... Pentetate N0000166195 Technetium Tc 99m Pyrophosphate N0000166769 Technetium Tc 99m Sestamibi N0000166203 Technetium Tc 99m ... Acid N0000006863 Technetium Tc 99m Disofenin N0000166771 Technetium Tc 99m Exametazime N0000170259 Technetium ...
The role of 99mtechnetium (Tc) diethyl-iminodiacetic acid (EHIDA) hepatobiliary scintigraphy in the diagnosis of a rare cause ... Sivelli R, Farinon AM, Sianesi M, Percudani M, Ugolotti G, Calbiani B. Technetium-99m HIDA hepatobiliary scanning in evaluation ...
Technetium Tc 99m Diethyl-iminodiacetic Acid [D02.691.825.445] * Technetium Tc 99m Dimercaptosuccinic Acid [D02.691.825.468] ... Tc 99m-Albumin Tc 99m-Albumin Colloid Tc-99m-HAM Tc-99m-MAA Tc-99m-Microalbumin Tc-HAMM Tc99m-Albumin Technetium-99m Albumin ... Tc 99m-Albumin Broader Concept UI. M0021096. Registry Number. 0. Terms. Tc 99m-Albumin Preferred Term Term UI T040163. Date06/ ... Technetium Tc 99m Aggregated Albumin Preferred Term Term UI T040159. Date01/01/1999. LexicalTag ABX. ThesaurusID NLM (1985). ...

No FAQ available that match "technetium tc 99m diethyl iminodiacetic acid"